Similar articles

• Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.

  Glass AG, Lacey JV Jr, Carreon JD, Hoover RN. Glass AG, et al. J Natl Cancer Inst. 2007 Aug 1;99(15):1152-61. doi: 10.1093/jnci/djm059. Epub 2007 Jul 24. J Natl Cancer Inst. 2007. PMID: 17652280
• Postmenopausal hormone therapy and breast cancer.

  [No authors listed] [No authors listed] Prescrire Int. 2009 Apr;18(100):66-7. Prescrire Int. 2009. PMID: 19585723
• Reviews of hormone replacement therapy evidence support findings in recently halted trial.

  Levenson D. Levenson D. Rep Med Guidel Outcomes Res. 2002 Sep 6;13(17):7-9. Rep Med Guidel Outcomes Res. 2002. PMID: 12572547 No abstract available.
• Postmenopausal hormone replacement therapy: does the progestin make a difference?

  Fylstra DL. Fylstra DL. J S C Med Assoc. 2002 Feb;98(1):12-9. J S C Med Assoc. 2002. PMID: 11859600 Review. No abstract available.
• Declining incidence of breast cancer after decreased use of hormone-replacement therapy: magnitude and time lags in different countries.

  Zbuk K, Anand SS. Zbuk K, et al. J Epidemiol Community Health. 2012 Jan;66(1):1-7. doi: 10.1136/jech.2008.083774. Epub 2011 Aug 28. J Epidemiol Community Health. 2012. PMID: 21875869 Review.